Develops stem cell dietary supplements for anti-aging and longevity.
Jun 2026Revenue $2.40M/yrExpenses $4.83M/yr
No trend
Figures by year
When will Stemtech be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Jun 2026, revenue was $2.40M and expenses $4.83M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2025 | $2.88M | $5.59M | −$2.71M |
| Dec 2024 | $5.05M | $7.44M | −$2.39M |
| Dec 2023 | $4.92M | $9.15M | −$4.22M |
| Dec 2022 | $4.56M | $9.58M | −$5.02M |
| Dec 2021 | $4.32M | $7.53M | −$3.21M |
| Dec 2020 | $4.38M | $5.82M | −$1.43M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.